ISSN: 1574-0153

Journal Home

Journal Guideline

Cancer Biomarkers Q2 Unclaimed

IOS Press BV Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Biomarkers is a journal indexed in SJR in Medicine (miscellaneous) and Genetics with an H index of 54. It has an SJR impact factor of 0,579 and it has a best quartile of Q2. It has an SJR impact factor of 0,579.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q2) Cancer Research (Q3) Genetics (Q3) Oncology (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,579

SJR Impact factor

54

H Index

84

Total Docs (Last Year)

404

Total Docs (3 years)

3243

Total Refs

958

Total Cites (3 years)

401

Citable Docs (3 years)

2.13

Cites/Doc (2 years)

38.61

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

Correlations of TNM staging and lymph node metastasis of gastric cancer with MRI features and VEGF expression

Gene expression profile of FVII and AR in primary prostate cancer

Tumor-infiltrating lymphocytes are associated with beta-catenin overexpression in breast cancer

Human kallikrein related peptidases 6 and 13 in combination with CA125 is a more sensitive test for ovarian cancer than CA125 alone

Salivary markers and risk factor data: A multivariate modeling approach for head and neck squamous cell carcinoma detection

Serum carbohydrate antigen 125 concentration as a superior predictor for serosal effusion at diagnosis and a prognostic factor in diffuse large B-cell lymphoma

The therapeutic role of inhibition of miR-328 on pulmonary carcinoma induced by chlamydia pneumoniae through targeting histone H2AX

Decreased expression of LncRNA MIR31HG in human bladder cancer

Loss of SMARCB1 expression in colon carcinoma

An association of selected ERCC2 and ERCC5 genes polymorphisms, the level of oxidative DNA damage and its repair efficiency with a risk of colorectal cancer in Polish population

Analysis of T cell receptor repertoire based on Vbeta chain in patients with breast cancer

Serum microRNA-218 is a potential biomarker for esophageal cancer

SHOW MORE ARTICLES

Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients

Downregulation of long noncoding RNA SNHG14 suppresses cell proliferation and invasion by regulating EZH2 in pancreatic ductal adenocarcinoma (PDAC)

Serum miR-658 induces metastasis of gastric cancer by activating PAX3-MET pathway: A population-based study

Serum miRNA-203 expression, a potential biomarker for recurrence and prognosis in papillary thyroid carcinoma

Predictive value of unmethylated RASSF1A on disease progression in non-small cell lung cancer patients receiving pemetrexed-based chemotherapy

The identification and characterization of a STAT5 gene signature in hematologic malignancies

Six-gene-based prognostic model predicts overall survival in patients with uveal melanoma

Urine CXCL1 as a biomarker for tumor detection and outcome prediction in bladder cancer

siRNA-mediated knockdown of JUB expression suppresses the proliferation of glioblastoma cells

Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis

Elevated lactic acid is a negative prognostic factor in metastatic lung cancer

The predictors of response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer